Idexx Laboratories Total Operating Expenses increased by 5.2% to $360.15M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.4%, from $306.85M to $360.15M. Over 3 years (FY 2022 to FY 2025), Total Operating Expenses shows an upward trend with a 5.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Rising expenses without a corresponding rise in revenue can indicate operational bloat or aggressive expansion efforts.
The sum of all costs required to run the business that are not directly tied to production, including R&D and SG&A. It r...
Investors compare this to revenue to assess the 'operating leverage' of a business model.
total_operating_expenses| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $276.39M | $276.39M | $276.39M | $276.39M | $273.21M | $273.21M | $273.21M | $273.21M | $294.11M | $355.36M | $292.15M | $308.97M | $306.85M | $321.69M | $328.51M | $342.51M | $360.15M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -1.2% | +0.0% | +0.0% | +0.0% | +7.7% | +20.8% | -17.8% | +5.8% | -0.7% | +4.8% | +2.1% | +4.3% | +5.2% |
| YoY Change | — | — | — | — | -1.2% | -1.2% | -1.2% | -1.2% | +7.7% | +30.1% | +6.9% | +13.1% | +4.3% | -9.5% | +12.4% | +10.9% | +17.4% |